Salisbury Foundation Trust

FOI_5195

Internal Reference Number: FOI_5195

Date Request Received: 31/07/2019 15:58:47

Date Request Replied To: 27/08/2019 09:07:28

This response was sent via: By Email

Request Summary: Ophthalmology services

Request Category: Media

 
Question Number 1:
Does your Trust have a policy on the use of unlicensed medicines? Please answer Yes or No. If yes, please provide a copy of the policy and all other relevant documentation
 
Answer To Question 1:
Yes policy can be found at https://viewer.microguide.global/guide/1000000300#content,b3c157e8-bdb6-4e96-9011-12a2069b4b54
 
Question Number 2:
Does your Trust have a policy or protocol on obtaining informed consent from patients when an unlicensed medicine is used? Please answer Yes or No. If yes, please provide copies of all relevant documentation, including copies of template informed consent materials, used to consent patients where an unlicensed medicine is to be administered
 
Answer To Question 2:
See Policy and appendices at https://viewer.microguide.global/guide/1000000300#content,b3c157e8-bdb6-4e96-9011-12a2069b4b54
 
Question Number 3:
Please state which Board level job role(s) is (are) responsible for patient safety and consenting
a. If no Board level job role(s) is (are) responsible for patient safety and consenting, please state which job role in the organisation is responsible for this
 
Answer To Question 3:
Director of Nursing
 
Question Number 4:
Does your Trust have, or intend to introduce, a policy that makes compounded bevacizumab routinely available to treat wet age-related macular degeneration? If Yes, please supply a copy of your policy
 
Answer To Question 4:
No
 
Question Number 5:
Over the past two years has your Trust, on more than one occasion, used compounded Avastin (bevacizumab) for the treatment of wet age-related macular degeneration? Please answer Yes or No
 
Answer To Question 5:
Yes
 
Question Number 6:
If yes to 5:
Was the compounded Avastin (bevacizumab) for the treatment of age-related macular degeneration produced within an aseptic department owned/run by the Trust? Please answer Yes or No
 
Answer To Question 6:
No
 
Question Number 7:
If yes to 6:
Does the Trust’s aseptic department, referred to above, currently hold an MHRA license for the manufacture of specials? Please answer Yes or No
 
Answer To Question 7:
N/A
 
Question Number 8:
When was the Trust’s aseptic department, referred to above, in answer to Q5 last inspected by the CQC?
 
Answer To Question 8:
N/A as answered no to Q6
 
Question Number 9:
If you answered no to question 5, but yes to question 4:
Please provide information regarding from whom your Trust has obtained/purchased compounded Avastin (bevacizumab). If you cannot provide the name of any commercial supplier, please provide as much information as possible
 
Answer To Question 9:
N/A as answered Yes to Q5 and no to Q4
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values